An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials.
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
Related Posts
-
Thanksgiving Throwback: Bowling with frozen turkeys was the weirdest way people celebrated
The bowlers were really winging it by using frozen turkeys.
-
New research suggests urban raccoons across the US show early signs of domestication
The clever, adaptable urban “trash panda” may be evolving a shorter snout — a key…
-
Conan Gray, Lainey Wilson and ‘KPop Demon Hunters’ at Macy’s Thanksgiving Day Parade. What to know
Here are some key things to know about the Macy’s Thanksgiving Day Parade and how…
-
The ultimate editor-approved holiday gift guide
Our experts from Good Housekeeping, Men’s Health, Women’s Health, Cosmopolitan and Delish share their top…
Leave a Reply